MP77-16 FIRST REPEATED BIOPSY REPRESENTS THE MOST INFORMATIVE PREDICTOR OF PROGRESSION-FREE SURVIVAL AT 3 YEARS FOLLOW-UP IN PATIENTS INCLUDED IN AN ACTIVE SURVEILLANCE PROTOCOL FOR LOW-RISK PROSTATE CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.